Home » Genzyme, After Months of Holding Out, Agrees to Be Sold to Sanofi-Aventis for $20.1B
Genzyme, After Months of Holding Out, Agrees to Be Sold to Sanofi-Aventis for $20.1B
It’s been a long time coming, but the sale of Genzyme, the Cambridge, MA-based biotech company, to pharma giant Sanofi-Aventis for $20.1 billion marks a landmark moment in the biotech industry here in Boston and beyond.
Xconomy
Xconomy
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May